Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial
Loading...
Date
2022
Other authors
Impact
Journal Title
Journal ISSN
Volume Title
Related resource
Citation
Journal or Serie
Neurology: Neuroimmunology & Neuroinflammation, 2022, vol. 9, núm. 3